NUT carcinoma in children and adolescents: An analysis of the European Cooperative Study Group on pediatric rare tumors (EXPeRT)

IF 4.5 2区医学 Q1 ONCOLOGY Lung Cancer Pub Date : 2025-02-19 DOI:10.1016/j.lungcan.2025.108449

Tim Flaadt , Lauriane Lemelle , Michael Abele , Calogero Virgone , Tal Ben-Ami , Denis Kachanov , Apostolos Pourtsidis , Andrea Ferrari , Gianni Bisogno , Ewa Bien , Nuno Jorge Dos Reis Farinha , Jan Godzinski , Yves Reguerre , Jelena Roganovic , Linus D. Kloker , Ulrich M. Lauer , Dominik T. Schneider , Ines B. Brecht , Daniel Orbach

{"title":"NUT carcinoma in children and adolescents: An analysis of the European Cooperative Study Group on pediatric rare tumors (EXPeRT)","authors":"Tim Flaadt , Lauriane Lemelle , Michael Abele , Calogero Virgone , Tal Ben-Ami , Denis Kachanov , Apostolos Pourtsidis , Andrea Ferrari , Gianni Bisogno , Ewa Bien , Nuno Jorge Dos Reis Farinha , Jan Godzinski , Yves Reguerre , Jelena Roganovic , Linus D. Kloker , Ulrich M. Lauer , Dominik T. Schneider , Ines B. Brecht , Daniel Orbach","doi":"10.1016/j.lungcan.2025.108449","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and Aims</h3><div>NUT carcinoma (NC) is a sporadic, highly aggressive tumor that primarily affects children, adolescents, and young adults and is characterized by the presence of somatic <em>NUTM1</em> rearrangements. This analysis by the European Cooperative Study Group for Pediatric Rare Tumors (<em>EXPeRT</em>) aims to fill the knowledge gap regarding the clinical characteristics of children with NC.</div></div><div><h3>Methods</h3><div>A retrospective case series of NC-patients aged 0–18 years treated between 2011 and 2023 was conducted using the <em>EXPeRT</em> database. Relevant clinical characteristics, including treatment and outcome were recorded.</div></div><div><h3>Results</h3><div>Twenty-seven patients with a median age of 13 years (range 7–18) were analyzed. Thirteen patients were initially misdiagnosed. Sixteen patients had thoracic and 11 extra-thoracic tumors, including three in the nasal/sinus region and two in the submandibular glands. Despite intense multimodal treatment, median event-free and overall survivals were 1.5 and 6.5 months, respectively.</div></div><div><h3>Conclusions</h3><div>Early diagnosis of NC by examination of the NUTM1 rearrangement in undifferentiated or poorly differentiated carcinomas is crucial in order to initiate specific and intensive therapy as quickly as possible. Similar to adult patients, only a minority of pediatric patients achieved prolonged survival. Therefore, the development of novel therapeutic strategies in future joint clinical trials is essential.</div></div>","PeriodicalId":18129,"journal":{"name":"Lung Cancer","volume":"201 ","pages":"Article 108449"},"PeriodicalIF":4.5000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lung Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0169500225000704","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background and Aims

NUT carcinoma (NC) is a sporadic, highly aggressive tumor that primarily affects children, adolescents, and young adults and is characterized by the presence of somatic NUTM1 rearrangements. This analysis by the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) aims to fill the knowledge gap regarding the clinical characteristics of children with NC.

Methods

A retrospective case series of NC-patients aged 0–18 years treated between 2011 and 2023 was conducted using the EXPeRT database. Relevant clinical characteristics, including treatment and outcome were recorded.

Results

Twenty-seven patients with a median age of 13 years (range 7–18) were analyzed. Thirteen patients were initially misdiagnosed. Sixteen patients had thoracic and 11 extra-thoracic tumors, including three in the nasal/sinus region and two in the submandibular glands. Despite intense multimodal treatment, median event-free and overall survivals were 1.5 and 6.5 months, respectively.

Conclusions

Early diagnosis of NC by examination of the NUTM1 rearrangement in undifferentiated or poorly differentiated carcinomas is crucial in order to initiate specific and intensive therapy as quickly as possible. Similar to adult patients, only a minority of pediatric patients achieved prolonged survival. Therefore, the development of novel therapeutic strategies in future joint clinical trials is essential.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

Lung Cancer 医学-呼吸系统

CiteScore

9.40

自引率

3.80%

发文量

407

审稿时长

25 days

期刊介绍： Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.